Overview


According to FutureWise analysis, the market for Small Animal Imaging (In-Vivo) Market in 2023 is US$ 2.98 billion, and is expected to reach US$ 6.04 billion by 2031 at a CAGR of 9.20%.

Small animal imaging refers to the use of various non-invasive imaging techniques, such as MRI scans, CT scans, PET scans, single-photon emission computed tomography (SPECT), and optical imaging, to study small animals, typically rodents like mice and rats, in real-time. Small animal imaging technology provides researchers with the ability to visualize and study the internal organs, physiological functions, and molecular processes of these animals without harming them. The imaging modalities used in small animal imaging can capture a wide range of information, including anatomical, functional, and molecular data, enabling researchers to investigate complex biological processes in vivo.

Small animal imaging is essential in preclinical research, particularly in the drug development process. It allows researchers to study the progression of diseases and to evaluate the efficacy and safety of potential treatments in animal models before moving on to human clinical trials. This approach saves time and resources and enables early identification of possible safety concerns in the medication development process. Small animal imaging also plays a critical role in basic research, as it enables researchers to investigate the fundamental biological processes that occur within living organisms. Researchers can use small animal imaging to study the development of diseases, the interactions between cells and tissues, and the function of organs and organ systems in vivo. This information is essential for understanding complex biological systems and developing new treatments for a wide range of diseases.

Advancements in imaging technology and a rising need for preclinical imaging in drug development and research have resulted in a consistent growth of the small animal imaging market in recent years. One major driver of the small animal imaging market is the increasing use of animal models in preclinical research. The ability to visualize small animals in real-time allows researchers to study disease progression and evaluate the efficacy of potential treatments before moving on to human clinical trials. This saves time and money by identifying potential issues earlier in the drug development process. Another factor driving the growth of the small animal imaging market is the increasing demand for personalized medicine. As personalized medicine becomes more prevalent, the need for targeted therapies and diagnostic tools will increase. Small animal imaging allows researchers to develop and test these targeted therapies and diagnostics in preclinical models before moving on to human trials. The increasing use of multimodal imaging also drives the small animal imaging market. Multimodal imaging combines two or more imaging modalities to provide more comprehensive information about the animals being studied. For example, combining PET and MRI can provide information about both metabolism and anatomical structure.

One major challenge faced by the small animal imaging market is the cost of imaging equipment and maintenance. The high cost of imaging equipment can make it difficult for smaller research institutions to invest in the technology. Additionally, the maintenance of imaging equipment can be expensive, requiring trained technicians and specialized parts.

FutureWise Market Research has published a report that provides an insightful analysis of Small Animal Imaging (In-Vivo) Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Small Animal Imaging (In-Vivo) Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • PerkinElmer, Inc.
  • Bruker Corporation
  • FUJIFILM Holdings Corporation
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions Ltd.
  • Aspect Imaging
  • LI-COR Biosciences
  • Trifoil Imaging
  • Miltenyi Biotec GmbH

By Modality

  • Optical Imaging Systems
    • Bioluminescence/Fluorescence Imaging Systems
    • Standalone Fluorescence Imaging Systems
    • (Optical + X-Ray)/(Optical + CT) Systems
  • Nuclear Imaging Systems
    • Micro-Pet Systems
      • Standalone Pet Systems
      • Pet/CT Systems
      • Pet/MRI Systems
    • Micro-Spect Systems
      • Standalone Spect Systems
      • Spect/CT Systems
      • Spect/MRI Systems
    • Trimodality (Spect/Pet/CT) Systems
  • Micro-MRI
  • Micro-Ultrasound
  • Micro-CT
  • Photoacoustic Imaging Systems
  • Magnetic Particle Imaging (MPI) Systems

By Reagent  

  • Optical Imaging Reagents
    • Bioluminescent Imaging Reagents
      • Luciferins
      • Proluciferins
      • Coelenterazine
      • Other Bioluminescent Imaging Reagents
    • Fluorescent Imaging Reagents
      • Green Fluorescent Proteins
      • Red Fluorescent Proteins
      • Infrared Dyes
      • Other Fluorescent Imaging Reagents
  • Nuclear Imaging Reagents
    • Pet Tracers
      • Fluorine-18-Based Small Animal Pet Tracers
      • Carbon-11-Based Small Animal Pet Tracers
      • Copper-64-Based Small Animal Pet Tracers
      • Other Pet Tracers
    • Spect Probes
      • Technetium-99m-Based Small Animal Spect Probes
      • Iodine-131-Based Small Animal Spect Probes
      • Gallium-67-Based Small Animal Spect Probes
      • Thallium-201-Based Small Animal Spect Probes
      • Other Spect Probes
  • MRI Contrast Agents
    • Gadolinium-Based Small Animal Contrast Agents
    • Iron-Based Small Animal Contrast Agents
    • Manganese-Based Small Animal Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents
    • Iodine-Based Small Animal CT Contrast Agents
    • Barium-Based Small Animal CT Contrast Agents
    • Gold Nanoparticles
    • Gastrografin-Based Small Animal CT Contrast Agents

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. North America currently dominates the small animal imaging (In-Vivo) market, both in terms of market share and technological advancements. The U.S. and Canada are the major contributors to the growth of the small animal imaging market in North America. The dominance of North America in the small animal imaging market can be attributed to several factors, including the presence of major players in the region, high healthcare expenditure, well-established healthcare infrastructure, and the increasing demand for preclinical imaging in drug development and research. Additionally, the growing focus on personalized medicine and the need for targeted therapies and diagnostics have also contributed to the expansion of the small animal imaging market in North America.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Small Animal Imaging (In-Vivo) Market By Modality, By Reagent and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Small Animal Imaging (In-Vivo) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Small Animal Imaging (In-Vivo) Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Small Animal Imaging (In-Vivo) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Small Animal Imaging (In-Vivo) Market, By Modality Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Optical Imaging Systems
         1.1. Bioluminescence/Fluorescence Imaging Systems
         1.2. Standalone Fluorescence Imaging Systems
         1.3. (Optical + X-Ray)/(Optical + CT) Systems
        2. Nuclear Imaging Systems
         2.1. Micro-Pet Systems
          2.1.1. Standalone Pet Systems
          2.1.2. Pet/CT Systems
          2.1.3. Pet/MRI Systems
         2.2. Micro-Spect Systems
          2.2.1. Standalone Spect Systems
          2.2.2. Spect/CT Systems
          2.2.3. Spect/MRI Systems
         2.3. Trimodality (Spect/Pet/CT) Systems
        3. Micro-MRI
        4. Micro-Ultrasound
        5. Micro-CT
        6. Photoacoustic Imaging Systems
        7. Magnetic Particle Imaging (MPI) Systems

  • 8.   Small Animal Imaging (In-Vivo) Market, By Reagent Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Optical Imaging Reagents
         1.1. Bioluminescent Imaging Reagents
          1.1.1. Luciferins
          1.1.2. Proluciferins
          1.1.3. Coelenterazine
          1.1.4. Other Bioluminescent Imaging Reagents
         1.2 . Fluorescent Imaging Reagents
          1.2.1. Green Fluorescent Proteins
          1.2.2. Red Fluorescent Proteins
          1.2.3. Infrared Dyes
          1.2.4. Other Fluorescent Imaging Reagents
        2. Nuclear Imaging Reagents
         2.1. Pet Tracers
          2.1.1. Fluorine-18-Based Small Animal Pet Tracers
          2.1.2. Carbon-11-Based Small Animal Pet Tracers
          2.1.3. Copper-64-Based Small Animal Pet Tracers
          2.1.4. Other Pet Tracers
         2.2. Spect Probes
          2.2.1. Technetium-99m-Based Small Animal Spect Probes
          2.2.2. Iodine-131-Based Small Animal Spect Probes
          2.2.3. Gallium-67-Based Small Animal Spect Probes
          2.2.4. Thallium-201-Based Small Animal Spect Probes
          2.2.5. Other Spect Probes
        3. MRI Contrast Agents
         3.1. Gadolinium-Based Small Animal Contrast Agents
         3.2. Iron-Based Small Animal Contrast Agents
         3.3. Manganese-Based Small Animal Contrast Agents
        4. Ultrasound Contrast Agents
        5. CT Contrast Agents
         5.1. Iodine-Based Small Animal CT Contrast Agents
         5.2. Barium-Based Small Animal CT Contrast Agents
         5.3. Gold Nanoparticles
         5.4. Gastrografin-Based Small Animal CT Contrast Agents

  • 9.   North America Small Animal Imaging (In-Vivo) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Small Animal Imaging (In-Vivo) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Small Animal Imaging (In-Vivo) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Small Animal Imaging (In-Vivo) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •    1. PerkinElmer Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
          2. Bruker Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
          3. FUJIFILM Holdings Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Mediso Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
          5. MILabs B.V.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MR Solutions Ltd.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Aspect Imaging
         7.1. Company Overview
         7.1. Product Portfolio
         7.2. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. LI-COR Biosciences
         8.1. Company Overview
         8.1. Product Portfolio
         8.2. SWOT Analysis
         8.3. Financial Overview
         8.4. Strategic Overview
        9. Trifoil Imaging
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Miltenyi Biotec GmbH
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients